Report Overview
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
The global Gabapentin Drug market size was estimated at USD 1542 million in 2023 and is projected to reach USD 2119.93 million by 2032, exhibiting a CAGR of 3.60% during the forecast period.
North America Gabapentin Drug market size was estimated at USD 426.98 million in 2023, at a CAGR of 3.09% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Gabapentin Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gabapentin Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gabapentin Drug market in any manner.
Global Gabapentin Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Depomed
Apotex
Teva
Acella Pharmaceuticals
Taro
Sun Pharmaceutical
Glenmark
Amneal Pharmaceuticals
Aurobindo Pharma
Zydus Pharmaceuticals
Hi-Tech Pharmaceuticals
Marksans Pharma
Mylan
InvaGen Pharmaceuticals
Alkem Laboratories
Tris Pharma
ACI HealthCare Limited
Jiangsu Hengrui Medicine
CSPC Ouyi Pharmaceutical
Sciegen Pharmaceuticals
Epic Pharma
Lupin Limited
Market Segmentation (by Type)
Capsule
Tablet
Oral Solution
Market Segmentation (by Application)
Postherpetic Neuralgia in Adults
Partial Onset Seizures
Others
Geographic Segmentation
� North America (USA, Canada, Mexico)
� Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
� Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
� South America (Brazil, Argentina, Columbia, Rest of South America)
� The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
� Industry drivers, restraints, and opportunities covered in the study
� Neutral perspective on the market performance
� Recent industry trends and developments
� Competitive landscape & strategies of key players
� Potential & niche segments and regions exhibiting promising growth covered
� Historical, current, and projected market size, in terms of value
� In-depth analysis of the Gabapentin Drug Market
� Overview of the regional outlook of the Gabapentin Drug Market:
Key Reasons to Buy this Report:
� Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
� This enables you to anticipate market changes to remain ahead of your competitors
� You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
� The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
� Provision of market value data for each segment and sub-segment
� Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
� Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
� Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
� Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
� The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
� Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
� Provides insight into the market through Value Chain
� Market dynamics scenario, along with growth opportunities of the market in the years to come
� 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gabapentin Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gabapentin Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Gabapentin Drug
1.2 Key Market Segments
1.2.1 Gabapentin Drug Segment by Type
1.2.2 Gabapentin Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Gabapentin Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Gabapentin Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Gabapentin Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Gabapentin Drug Market Competitive Landscape
3.1 Global Gabapentin Drug Sales by Manufacturers (2019-2025)
3.2 Global Gabapentin Drug Revenue Market Share by Manufacturers (2019-2025)
3.3 Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gabapentin Drug Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Gabapentin Drug Sales Sites, Area Served, Product Type
3.6 Gabapentin Drug Market Competitive Situation and Trends
3.6.1 Gabapentin Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gabapentin Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Gabapentin Drug Industry Chain Analysis
4.1 Gabapentin Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Gabapentin Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Gabapentin Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gabapentin Drug Sales Market Share by Type (2019-2025)
6.3 Global Gabapentin Drug Market Size Market Share by Type (2019-2025)
6.4 Global Gabapentin Drug Price by Type (2019-2025)
7 Gabapentin Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gabapentin Drug Market Sales by Application (2019-2025)
7.3 Global Gabapentin Drug Market Size (M USD) by Application (2019-2025)
7.4 Global Gabapentin Drug Sales Growth Rate by Application (2019-2025)
8 Gabapentin Drug Market Consumption by Region
8.1 Global Gabapentin Drug Sales by Region
8.1.1 Global Gabapentin Drug Sales by Region
8.1.2 Global Gabapentin Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Gabapentin Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gabapentin Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gabapentin Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gabapentin Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gabapentin Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Gabapentin Drug Market Production by Region
9.1 Global Production of Gabapentin Drug by Region (2019-2025)
9.2 Global Gabapentin Drug Revenue Market Share by Region (2019-2025)
9.3 Global Gabapentin Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Gabapentin Drug Production
9.4.1 North America Gabapentin Drug Production Growth Rate (2019-2025)
9.4.2 North America Gabapentin Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Gabapentin Drug Production
9.5.1 Europe Gabapentin Drug Production Growth Rate (2019-2025)
9.5.2 Europe Gabapentin Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Gabapentin Drug Production (2019-2025)
9.6.1 Japan Gabapentin Drug Production Growth Rate (2019-2025)
9.6.2 Japan Gabapentin Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Gabapentin Drug Production (2019-2025)
9.7.1 China Gabapentin Drug Production Growth Rate (2019-2025)
9.7.2 China Gabapentin Drug Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Pfizer
10.1.1 Pfizer Gabapentin Drug Basic Information
10.1.2 Pfizer Gabapentin Drug Product Overview
10.1.3 Pfizer Gabapentin Drug Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer Gabapentin Drug SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Depomed
10.2.1 Depomed Gabapentin Drug Basic Information
10.2.2 Depomed Gabapentin Drug Product Overview
10.2.3 Depomed Gabapentin Drug Product Market Performance
10.2.4 Depomed Business Overview
10.2.5 Depomed Gabapentin Drug SWOT Analysis
10.2.6 Depomed Recent Developments
10.3 Apotex
10.3.1 Apotex Gabapentin Drug Basic Information
10.3.2 Apotex Gabapentin Drug Product Overview
10.3.3 Apotex Gabapentin Drug Product Market Performance
10.3.4 Apotex Gabapentin Drug SWOT Analysis
10.3.5 Apotex Business Overview
10.3.6 Apotex Recent Developments
10.4 Teva
10.4.1 Teva Gabapentin Drug Basic Information
10.4.2 Teva Gabapentin Drug Product Overview
10.4.3 Teva Gabapentin Drug Product Market Performance
10.4.4 Teva Business Overview
10.4.5 Teva Recent Developments
10.5 Acella Pharmaceuticals
10.5.1 Acella Pharmaceuticals Gabapentin Drug Basic Information
10.5.2 Acella Pharmaceuticals Gabapentin Drug Product Overview
10.5.3 Acella Pharmaceuticals Gabapentin Drug Product Market Performance
10.5.4 Acella Pharmaceuticals Business Overview
10.5.5 Acella Pharmaceuticals Recent Developments
10.6 Taro
10.6.1 Taro Gabapentin Drug Basic Information
10.6.2 Taro Gabapentin Drug Product Overview
10.6.3 Taro Gabapentin Drug Product Market Performance
10.6.4 Taro Business Overview
10.6.5 Taro Recent Developments
10.7 Sun Pharmaceutical
10.7.1 Sun Pharmaceutical Gabapentin Drug Basic Information
10.7.2 Sun Pharmaceutical Gabapentin Drug Product Overview
10.7.3 Sun Pharmaceutical Gabapentin Drug Product Market Performance
10.7.4 Sun Pharmaceutical Business Overview
10.7.5 Sun Pharmaceutical Recent Developments
10.8 Glenmark
10.8.1 Glenmark Gabapentin Drug Basic Information
10.8.2 Glenmark Gabapentin Drug Product Overview
10.8.3 Glenmark Gabapentin Drug Product Market Performance
10.8.4 Glenmark Business Overview
10.8.5 Glenmark Recent Developments
10.9 Amneal Pharmaceuticals
10.9.1 Amneal Pharmaceuticals Gabapentin Drug Basic Information
10.9.2 Amneal Pharmaceuticals Gabapentin Drug Product Overview
10.9.3 Amneal Pharmaceuticals Gabapentin Drug Product Market Performance
10.9.4 Amneal Pharmaceuticals Business Overview
10.9.5 Amneal Pharmaceuticals Recent Developments
10.10 Aurobindo Pharma
10.10.1 Aurobindo Pharma Gabapentin Drug Basic Information
10.10.2 Aurobindo Pharma Gabapentin Drug Product Overview
10.10.3 Aurobindo Pharma Gabapentin Drug Product Market Performance
10.10.4 Aurobindo Pharma Business Overview
10.10.5 Aurobindo Pharma Recent Developments
10.11 Zydus Pharmaceuticals
10.11.1 Zydus Pharmaceuticals Gabapentin Drug Basic Information
10.11.2 Zydus Pharmaceuticals Gabapentin Drug Product Overview
10.11.3 Zydus Pharmaceuticals Gabapentin Drug Product Market Performance
10.11.4 Zydus Pharmaceuticals Business Overview
10.11.5 Zydus Pharmaceuticals Recent Developments
10.12 Hi-Tech Pharmaceuticals
10.12.1 Hi-Tech Pharmaceuticals Gabapentin Drug Basic Information
10.12.2 Hi-Tech Pharmaceuticals Gabapentin Drug Product Overview
10.12.3 Hi-Tech Pharmaceuticals Gabapentin Drug Product Market Performance
10.12.4 Hi-Tech Pharmaceuticals Business Overview
10.12.5 Hi-Tech Pharmaceuticals Recent Developments
10.13 Marksans Pharma
10.13.1 Marksans Pharma Gabapentin Drug Basic Information
10.13.2 Marksans Pharma Gabapentin Drug Product Overview
10.13.3 Marksans Pharma Gabapentin Drug Product Market Performance
10.13.4 Marksans Pharma Business Overview
10.13.5 Marksans Pharma Recent Developments
10.14 Mylan
10.14.1 Mylan Gabapentin Drug Basic Information
10.14.2 Mylan Gabapentin Drug Product Overview
10.14.3 Mylan Gabapentin Drug Product Market Performance
10.14.4 Mylan Business Overview
10.14.5 Mylan Recent Developments
10.15 InvaGen Pharmaceuticals
10.15.1 InvaGen Pharmaceuticals Gabapentin Drug Basic Information
10.15.2 InvaGen Pharmaceuticals Gabapentin Drug Product Overview
10.15.3 InvaGen Pharmaceuticals Gabapentin Drug Product Market Performance
10.15.4 InvaGen Pharmaceuticals Business Overview
10.15.5 InvaGen Pharmaceuticals Recent Developments
10.16 Alkem Laboratories
10.16.1 Alkem Laboratories Gabapentin Drug Basic Information
10.16.2 Alkem Laboratories Gabapentin Drug Product Overview
10.16.3 Alkem Laboratories Gabapentin Drug Product Market Performance
10.16.4 Alkem Laboratories Business Overview
10.16.5 Alkem Laboratories Recent Developments
10.17 Tris Pharma
10.17.1 Tris Pharma Gabapentin Drug Basic Information
10.17.2 Tris Pharma Gabapentin Drug Product Overview
10.17.3 Tris Pharma Gabapentin Drug Product Market Performance
10.17.4 Tris Pharma Business Overview
10.17.5 Tris Pharma Recent Developments
10.18 ACI HealthCare Limited
10.18.1 ACI HealthCare Limited Gabapentin Drug Basic Information
10.18.2 ACI HealthCare Limited Gabapentin Drug Product Overview
10.18.3 ACI HealthCare Limited Gabapentin Drug Product Market Performance
10.18.4 ACI HealthCare Limited Business Overview
10.18.5 ACI HealthCare Limited Recent Developments
10.19 Jiangsu Hengrui Medicine
10.19.1 Jiangsu Hengrui Medicine Gabapentin Drug Basic Information
10.19.2 Jiangsu Hengrui Medicine Gabapentin Drug Product Overview
10.19.3 Jiangsu Hengrui Medicine Gabapentin Drug Product Market Performance
10.19.4 Jiangsu Hengrui Medicine Business Overview
10.19.5 Jiangsu Hengrui Medicine Recent Developments
10.20 CSPC Ouyi Pharmaceutical
10.20.1 CSPC Ouyi Pharmaceutical Gabapentin Drug Basic Information
10.20.2 CSPC Ouyi Pharmaceutical Gabapentin Drug Product Overview
10.20.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Product Market Performance
10.20.4 CSPC Ouyi Pharmaceutical Business Overview
10.20.5 CSPC Ouyi Pharmaceutical Recent Developments
10.21 Sciegen Pharmaceuticals
10.21.1 Sciegen Pharmaceuticals Gabapentin Drug Basic Information
10.21.2 Sciegen Pharmaceuticals Gabapentin Drug Product Overview
10.21.3 Sciegen Pharmaceuticals Gabapentin Drug Product Market Performance
10.21.4 Sciegen Pharmaceuticals Business Overview
10.21.5 Sciegen Pharmaceuticals Recent Developments
10.22 Epic Pharma
10.22.1 Epic Pharma Gabapentin Drug Basic Information
10.22.2 Epic Pharma Gabapentin Drug Product Overview
10.22.3 Epic Pharma Gabapentin Drug Product Market Performance
10.22.4 Epic Pharma Business Overview
10.22.5 Epic Pharma Recent Developments
10.23 Lupin Limited
10.23.1 Lupin Limited Gabapentin Drug Basic Information
10.23.2 Lupin Limited Gabapentin Drug Product Overview
10.23.3 Lupin Limited Gabapentin Drug Product Market Performance
10.23.4 Lupin Limited Business Overview
10.23.5 Lupin Limited Recent Developments
11 Gabapentin Drug Market Forecast by Region
11.1 Global Gabapentin Drug Market Size Forecast
11.2 Global Gabapentin Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gabapentin Drug Market Size Forecast by Country
11.2.3 Asia Pacific Gabapentin Drug Market Size Forecast by Region
11.2.4 South America Gabapentin Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Gabapentin Drug by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Gabapentin Drug Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Gabapentin Drug by Type (2025-2032)
12.1.2 Global Gabapentin Drug Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Gabapentin Drug by Type (2025-2032)
12.2 Global Gabapentin Drug Market Forecast by Application (2025-2032)
12.2.1 Global Gabapentin Drug Sales (K MT) Forecast by Application
12.2.2 Global Gabapentin Drug Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gabapentin Drug Market Size Comparison by Region (M USD)
Table 5. Global Gabapentin Drug Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Gabapentin Drug Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Gabapentin Drug Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Gabapentin Drug Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin Drug as of 2022)
Table 10. Global Market Gabapentin Drug Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Gabapentin Drug Sales Sites and Area Served
Table 12. Manufacturers Gabapentin Drug Product Type
Table 13. Global Gabapentin Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gabapentin Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gabapentin Drug Market Challenges
Table 22. Global Gabapentin Drug Sales by Type (K MT)
Table 23. Global Gabapentin Drug Market Size by Type (M USD)
Table 24. Global Gabapentin Drug Sales (K MT) by Type (2019-2025)
Table 25. Global Gabapentin Drug Sales Market Share by Type (2019-2025)
Table 26. Global Gabapentin Drug Market Size (M USD) by Type (2019-2025)
Table 27. Global Gabapentin Drug Market Size Share by Type (2019-2025)
Table 28. Global Gabapentin Drug Price (USD/MT) by Type (2019-2025)
Table 29. Global Gabapentin Drug Sales (K MT) by Application
Table 30. Global Gabapentin Drug Market Size by Application
Table 31. Global Gabapentin Drug Sales by Application (2019-2025) & (K MT)
Table 32. Global Gabapentin Drug Sales Market Share by Application (2019-2025)
Table 33. Global Gabapentin Drug Sales by Application (2019-2025) & (M USD)
Table 34. Global Gabapentin Drug Market Share by Application (2019-2025)
Table 35. Global Gabapentin Drug Sales Growth Rate by Application (2019-2025)
Table 36. Global Gabapentin Drug Sales by Region (2019-2025) & (K MT)
Table 37. Global Gabapentin Drug Sales Market Share by Region (2019-2025)
Table 38. North America Gabapentin Drug Sales by Country (2019-2025) & (K MT)
Table 39. Europe Gabapentin Drug Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Gabapentin Drug Sales by Region (2019-2025) & (K MT)
Table 41. South America Gabapentin Drug Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Gabapentin Drug Sales by Region (2019-2025) & (K MT)
Table 43. Global Gabapentin Drug Production (K MT) by Region (2019-2025)
Table 44. Global Gabapentin Drug Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Gabapentin Drug Revenue Market Share by Region (2019-2025)
Table 46. Global Gabapentin Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Gabapentin Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Gabapentin Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Gabapentin Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Gabapentin Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Pfizer Gabapentin Drug Basic Information
Table 52. Pfizer Gabapentin Drug Product Overview
Table 53. Pfizer Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Pfizer Business Overview
Table 55. Pfizer Gabapentin Drug SWOT Analysis
Table 56. Pfizer Recent Developments
Table 57. Depomed Gabapentin Drug Basic Information
Table 58. Depomed Gabapentin Drug Product Overview
Table 59. Depomed Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Depomed Business Overview
Table 61. Depomed Gabapentin Drug SWOT Analysis
Table 62. Depomed Recent Developments
Table 63. Apotex Gabapentin Drug Basic Information
Table 64. Apotex Gabapentin Drug Product Overview
Table 65. Apotex Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Apotex Gabapentin Drug SWOT Analysis
Table 67. Apotex Business Overview
Table 68. Apotex Recent Developments
Table 69. Teva Gabapentin Drug Basic Information
Table 70. Teva Gabapentin Drug Product Overview
Table 71. Teva Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Teva Business Overview
Table 73. Teva Recent Developments
Table 74. Acella Pharmaceuticals Gabapentin Drug Basic Information
Table 75. Acella Pharmaceuticals Gabapentin Drug Product Overview
Table 76. Acella Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Acella Pharmaceuticals Business Overview
Table 78. Acella Pharmaceuticals Recent Developments
Table 79. Taro Gabapentin Drug Basic Information
Table 80. Taro Gabapentin Drug Product Overview
Table 81. Taro Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Taro Business Overview
Table 83. Taro Recent Developments
Table 84. Sun Pharmaceutical Gabapentin Drug Basic Information
Table 85. Sun Pharmaceutical Gabapentin Drug Product Overview
Table 86. Sun Pharmaceutical Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Sun Pharmaceutical Business Overview
Table 88. Sun Pharmaceutical Recent Developments
Table 89. Glenmark Gabapentin Drug Basic Information
Table 90. Glenmark Gabapentin Drug Product Overview
Table 91. Glenmark Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Glenmark Business Overview
Table 93. Glenmark Recent Developments
Table 94. Amneal Pharmaceuticals Gabapentin Drug Basic Information
Table 95. Amneal Pharmaceuticals Gabapentin Drug Product Overview
Table 96. Amneal Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Amneal Pharmaceuticals Business Overview
Table 98. Amneal Pharmaceuticals Recent Developments
Table 99. Aurobindo Pharma Gabapentin Drug Basic Information
Table 100. Aurobindo Pharma Gabapentin Drug Product Overview
Table 101. Aurobindo Pharma Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Aurobindo Pharma Business Overview
Table 103. Aurobindo Pharma Recent Developments
Table 104. Zydus Pharmaceuticals Gabapentin Drug Basic Information
Table 105. Zydus Pharmaceuticals Gabapentin Drug Product Overview
Table 106. Zydus Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Zydus Pharmaceuticals Business Overview
Table 108. Zydus Pharmaceuticals Recent Developments
Table 109. Hi-Tech Pharmaceuticals Gabapentin Drug Basic Information
Table 110. Hi-Tech Pharmaceuticals Gabapentin Drug Product Overview
Table 111. Hi-Tech Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. Hi-Tech Pharmaceuticals Business Overview
Table 113. Hi-Tech Pharmaceuticals Recent Developments
Table 114. Marksans Pharma Gabapentin Drug Basic Information
Table 115. Marksans Pharma Gabapentin Drug Product Overview
Table 116. Marksans Pharma Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Marksans Pharma Business Overview
Table 118. Marksans Pharma Recent Developments
Table 119. Mylan Gabapentin Drug Basic Information
Table 120. Mylan Gabapentin Drug Product Overview
Table 121. Mylan Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. Mylan Business Overview
Table 123. Mylan Recent Developments
Table 124. InvaGen Pharmaceuticals Gabapentin Drug Basic Information
Table 125. InvaGen Pharmaceuticals Gabapentin Drug Product Overview
Table 126. InvaGen Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 127. InvaGen Pharmaceuticals Business Overview
Table 128. InvaGen Pharmaceuticals Recent Developments
Table 129. Alkem Laboratories Gabapentin Drug Basic Information
Table 130. Alkem Laboratories Gabapentin Drug Product Overview
Table 131. Alkem Laboratories Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 132. Alkem Laboratories Business Overview
Table 133. Alkem Laboratories Recent Developments
Table 134. Tris Pharma Gabapentin Drug Basic Information
Table 135. Tris Pharma Gabapentin Drug Product Overview
Table 136. Tris Pharma Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 137. Tris Pharma Business Overview
Table 138. Tris Pharma Recent Developments
Table 139. ACI HealthCare Limited Gabapentin Drug Basic Information
Table 140. ACI HealthCare Limited Gabapentin Drug Product Overview
Table 141. ACI HealthCare Limited Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 142. ACI HealthCare Limited Business Overview
Table 143. ACI HealthCare Limited Recent Developments
Table 144. Jiangsu Hengrui Medicine Gabapentin Drug Basic Information
Table 145. Jiangsu Hengrui Medicine Gabapentin Drug Product Overview
Table 146. Jiangsu Hengrui Medicine Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 147. Jiangsu Hengrui Medicine Business Overview
Table 148. Jiangsu Hengrui Medicine Recent Developments
Table 149. CSPC Ouyi Pharmaceutical Gabapentin Drug Basic Information
Table 150. CSPC Ouyi Pharmaceutical Gabapentin Drug Product Overview
Table 151. CSPC Ouyi Pharmaceutical Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 152. CSPC Ouyi Pharmaceutical Business Overview
Table 153. CSPC Ouyi Pharmaceutical Recent Developments
Table 154. Sciegen Pharmaceuticals Gabapentin Drug Basic Information
Table 155. Sciegen Pharmaceuticals Gabapentin Drug Product Overview
Table 156. Sciegen Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 157. Sciegen Pharmaceuticals Business Overview
Table 158. Sciegen Pharmaceuticals Recent Developments
Table 159. Epic Pharma Gabapentin Drug Basic Information
Table 160. Epic Pharma Gabapentin Drug Product Overview
Table 161. Epic Pharma Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 162. Epic Pharma Business Overview
Table 163. Epic Pharma Recent Developments
Table 164. Lupin Limited Gabapentin Drug Basic Information
Table 165. Lupin Limited Gabapentin Drug Product Overview
Table 166. Lupin Limited Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 167. Lupin Limited Business Overview
Table 168. Lupin Limited Recent Developments
Table 169. Global Gabapentin Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 170. Global Gabapentin Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 171. North America Gabapentin Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 172. North America Gabapentin Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 173. Europe Gabapentin Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 174. Europe Gabapentin Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 175. Asia Pacific Gabapentin Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 176. Asia Pacific Gabapentin Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 177. South America Gabapentin Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 178. South America Gabapentin Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 179. Middle East and Africa Gabapentin Drug Consumption Forecast by Country (2025-2032) & (Units)
Table 180. Middle East and Africa Gabapentin Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 181. Global Gabapentin Drug Sales Forecast by Type (2025-2032) & (K MT)
Table 182. Global Gabapentin Drug Market Size Forecast by Type (2025-2032) & (M USD)
Table 183. Global Gabapentin Drug Price Forecast by Type (2025-2032) & (USD/MT)
Table 184. Global Gabapentin Drug Sales (K MT) Forecast by Application (2025-2032)
Table 185. Global Gabapentin Drug Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Gabapentin Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gabapentin Drug Market Size (M USD), 2019-2032
Figure 5. Global Gabapentin Drug Market Size (M USD) (2019-2032)
Figure 6. Global Gabapentin Drug Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gabapentin Drug Market Size by Country (M USD)
Figure 11. Gabapentin Drug Sales Share by Manufacturers in 2023
Figure 12. Global Gabapentin Drug Revenue Share by Manufacturers in 2023
Figure 13. Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gabapentin Drug Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gabapentin Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gabapentin Drug Market Share by Type
Figure 18. Sales Market Share of Gabapentin Drug by Type (2019-2025)
Figure 19. Sales Market Share of Gabapentin Drug by Type in 2023
Figure 20. Market Size Share of Gabapentin Drug by Type (2019-2025)
Figure 21. Market Size Market Share of Gabapentin Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gabapentin Drug Market Share by Application
Figure 24. Global Gabapentin Drug Sales Market Share by Application (2019-2025)
Figure 25. Global Gabapentin Drug Sales Market Share by Application in 2023
Figure 26. Global Gabapentin Drug Market Share by Application (2019-2025)
Figure 27. Global Gabapentin Drug Market Share by Application in 2023
Figure 28. Global Gabapentin Drug Sales Growth Rate by Application (2019-2025)
Figure 29. Global Gabapentin Drug Sales Market Share by Region (2019-2025)
Figure 30. North America Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Gabapentin Drug Sales Market Share by Country in 2023
Figure 32. U.S. Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Gabapentin Drug Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Gabapentin Drug Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Gabapentin Drug Sales Market Share by Country in 2023
Figure 37. Germany Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Gabapentin Drug Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Gabapentin Drug Sales Market Share by Region in 2023
Figure 44. China Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Gabapentin Drug Sales and Growth Rate (K MT)
Figure 50. South America Gabapentin Drug Sales Market Share by Country in 2023
Figure 51. Brazil Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Gabapentin Drug Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Gabapentin Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Gabapentin Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Gabapentin Drug Production Market Share by Region (2019-2025)
Figure 62. North America Gabapentin Drug Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Gabapentin Drug Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Gabapentin Drug Production (K MT) Growth Rate (2019-2025)
Figure 65. China Gabapentin Drug Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Gabapentin Drug Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Gabapentin Drug Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Gabapentin Drug Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Gabapentin Drug Market Share Forecast by Type (2025-2032)
Figure 70. Global Gabapentin Drug Sales Forecast by Application (2025-2032)
Figure 71. Global Gabapentin Drug Market Share Forecast by Application (2025-2032)
